CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

STU:1CG (Switzerland)   Ordinary Shares
€ 40.80 (0%) Sep 12
At Loss
P/B:
1.95
Market Cap:
€ 3.55B ($ 3.94B)
Enterprise V:
€ 3.31B ($ 3.67B)
Volume:
-
Avg Vol (2M):
-
Trade In:

CRISPR Therapeutics AG Operating Data

CRISPR Therapeutics AG Competitors' Latest Operating Data

Operating data not available.

CRISPR Therapeutics AG (STU:1CG) Operating Data Charts